Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • Article
  • Harvard Business Review

The Board's New Innovation Imperative: Directors Need to Rethink Their Roles and Their Attitude to Risk

By: Linda A. Hill and George Davis
  • Format:Print
ShareBar

Abstract

As firms scramble for competitive advantage, boards—once the cautious voices urging management to mitigate risk—are now calling for breakthrough innovation. Indeed, avoiding risk is now seen as the riskiest proposition of all. In speaking with CEOs and board members from a range of industries, the authors identified four common obstacles most boards face in governing innovation: an outdated risk agenda, insufficient time, lack of expertise, and a relationship with management that needs retuning. Embracing innovation and its inherent risks requires that boards and senior management develop new ways of working together. To bolster out-of-the-box thinking at their companies, boards should promote diversity among members. They should foster "creative abrasion" to keep ideas flowing and rethink traditional methods of governing. And they must learn to embrace and encourage risk.

Keywords

Governing And Advisory Boards; Innovation Leadership; Risk And Uncertainty; Corporate Governance

Citation

Hill, Linda A., and George Davis. "The Board's New Innovation Imperative: Directors Need to Rethink Their Roles and Their Attitude to Risk." Harvard Business Review 95, no. 6 (November–December 2017): 102–109.
  • Find it at Harvard
  • Register to Read

About The Author

Linda A. Hill

Organizational Behavior
→More Publications

More from the Authors

    • December 2020 (Revised February 2021)
    • Faculty Research

    Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (B)

    By: Linda A. Hill and Emily Tedards
    • The Bridge

    Incorporating the Arts to Create Technical Leaders of the Future

    By: Linda A. Hill
    • Fall 2020
    • MIT Sloan Management Review

    Being the Agile Boss

    By: Linda A. Hill
More from the Authors
  • Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (B) By: Linda A. Hill and Emily Tedards
  • Incorporating the Arts to Create Technical Leaders of the Future By: Linda A. Hill
  • Being the Agile Boss By: Linda A. Hill
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Digital Accessibility
Copyright © President & Fellows of Harvard College